Novus International, Inc.; Filing of Food Additive Petition (Animal Use); Correction, 85972 [2016-28656]
Download as PDF
<![CDATA[
85972
Federal Register / Vol. 81, No. 229 / Tuesday, November 29, 2016 / Notices
TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued
Number of
respondents
Activity
Number of completes ...............................................
Number of
responses per
respondent
240
Total annual
responses
Average burden
per response
(in hours)
Total hours
1
240
0.42 (25 minutes) ......
101
Main Study
Number to complete the screener (assumes 50%
eligibility).
Number of completes ...............................................
1,785
1
1,785
0.08 (5 minutes) ........
143
1,272
1
1,272
0.42 (25 minutes) ......
534
Total hours ........................................................
........................
........................
........................
....................................
805
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
References
The following references are on
display in the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852, and are
available for viewing by interested
persons between 9 a.m. and 4 p.m.,
Monday through Friday; they are also
available electronically at https://
www.regulations.gov. FDA has verified
the Web site addresses, as of the date
this document publishes in the Federal
Register, but Web sites are subject to
change over time.
1. Hall R.H. and P. Hanna ‘‘The Impact of
Web page Text-background Colour
Combinations on Readability, Retention,
Aesthetics, and Behavioural Intention.’’
Behavior & Information Technology. vol.
23 pp. 183–95, 2004.
2. Baur C and C. Prue ‘‘The CDC Clear
Communication Index is a Tool to
Prepare and Review Health
Information.’’ Health Promotion Practice.
vol.15 pp. 629–37, 2014.
3. Shrank W, J. Avorn, C. Rolon, and
P.Shekelle ‘‘Effect of Content and Format
of Prescription Drug Labels on
Readability, Understanding, and
Medication Use: A Systematic Review.’’
Annals of Pharmacotherapy. vol. 41 pp.
783–801, 2007.
4. Wogalter, M.S. and W.J. Vigilante. ‘‘Effects
of Label Format on Knowledge
Acquisition and Perceived Readability
by Younger and Older Adults.’’
Ergonomics. vol. 46 pp. 327–344, 2003.
5. Smither, J.A.A. and C.C. Braun
‘‘Readability of Prescription Drug Labels
by Older and Younger Adults.’’ Journal
of Clinical Psychology in Medical
Settings. vol. 1 pp. 149–59, 1994.
6. Foxman, E.R., D.D. Muehling and P.A.
Moore. ‘‘Disclaimer Footnotes in Ads:
Discrepancies Between Purpose and
Performance.’’ Journal of Public Policy
and Marketing. vol. 7 pp. 127–37, 1988.
7. Murray N.M., L.A. Manrai and A.K.
Manrai. ‘‘Public Policy Relating to
Consumer Comprehension of Television
Commercials: A Review and Some
Empirical Results.’’ Journal of Consumer
Policy. vol. 16 pp. 145–170, 1993.
8. Manrai, L.A., A.K. Manrai and N. Murray.
VerDate Sep<11>2014
17:48 Nov 28, 2016
Jkt 241001
‘‘Comprehension of Info-aid Supers in
Television Advertising for Social Ideas:
Implications for Public Policy’’. Journal
of Business Research. vol. 30 pp. 75–84,
1994.
9. Hill A. and L. Scharff. ‘‘Readability of
Computer Displays as a Function of
Colour, Saturation, and Background
Texture.’’ In D. Harns (Ed.) Engineering
Psychology and Cognitive Ergonomics
(vol. 4) Ashgate, Aldershot, United
Kingdom.
10. Shieh K-K. and C-C. Lin. ‘‘Effects of
Screen Type, Ambient Illumination, and
Color Combination on VDT Visual
Performance and Subjective Preference.’’
International Journal of Industrial
Ergonomics. vol. 26 pp. 527–36, 2000.
11. Tinker M.A. and D.G. Paterson. ‘‘Studies
of Typographical Factors Influencing
Speed of Reading. VII. Variations in
Color of Print and Background.’’ Journal
of Applied Psychology. vol. 15 pp. 471–
9, 1931.
12. Legge G.E., G.S. Rubin and A. Luebner
‘‘Psychophysics of reading. V. The Role
of Contrast in Normal Vision.’’ Vision
Research vol. 27 pp. 1165–77, 1987.
13. Kaufman D.W., J.P. Kelly, L. Rosenberg,
T.E. Anderson and A.A. Mitchell.
‘‘Recent Patterns of Medication Use in
the Ambulatory Adult Population of the
United States: The Slone Survey.’’
Journal of the American Medical
Association vol. 287 pp. 337–344, 2002.
Dated: November 22, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–28733 Filed 11–28–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2016–F–3880]
Novus International, Inc.; Filing of
Food Additive Petition (Animal Use);
Correction
AGENCY:
The Food and Drug
Administration is correcting a notice
entitled ‘‘Novus International, Inc.;
Filing of Food Additive Petition
(Animal Use)’’ that appeared in the
Federal Register of November 8, 2016
(81 FR 78528). The document
announced that Novus International,
Inc., has filed a petition proposing that
the food additive regulations be
amended to provide for the safe use of
poly (2-vinylpyridine-co-styrene) as a
nutrient protectant for methionine
hydroxy analog in animal food for beef
cattle, dairy cattle, and replacement
dairy heifers. Additionally, the petition
proposes that the food additive
regulations be amended to provide for
the safe use of ethyl cellulose as a
binder for methionine hydroxy analog to
be incorporated into animal food. The
document was published with the
incorrect docket number. This
document corrects that error.
SUMMARY:
Lisa
Granger, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 32,
Rm. 3330, Silver Spring, MD 20993–
0002, 301–796–9115, lisa.granger@
fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
In the
Federal Register of Tuesday, November
8, 2016, in FR Doc. 2016–26922, on page
78528, the following correction is made:
On page 78528, in the first column,
‘‘Docket No. FDA–2014–F–0452’’ is
corrected to read ‘‘Docket No. FDA–
2016–F–3880’’.
SUPPLEMENTARY INFORMATION:
Dated: November 22, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–28656 Filed 11–28–16; 8:45 am]
BILLING CODE 4164–01–P
Food and Drug Administration,
HHS
ACTION:
PO 00000
Notice; correction.
Frm 00053
Fmt 4703
Sfmt 9990
E:\FR\FM\29NON1.SGM
29NON1
]]>Agencies
[Federal Register Volume 81, Number 229 (Tuesday, November 29, 2016)]
[Notices]
[Page 85972]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-28656]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2016-F-3880]
Novus International, Inc.; Filing of Food Additive Petition
(Animal Use); Correction
AGENCY: Food and Drug Administration, HHS
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration is correcting a notice
entitled ``Novus International, Inc.; Filing of Food Additive Petition
(Animal Use)'' that appeared in the Federal Register of November 8,
2016 (81 FR 78528). The document announced that Novus International,
Inc., has filed a petition proposing that the food additive regulations
be amended to provide for the safe use of poly (2-vinylpyridine-co-
styrene) as a nutrient protectant for methionine hydroxy analog in
animal food for beef cattle, dairy cattle, and replacement dairy
heifers. Additionally, the petition proposes that the food additive
regulations be amended to provide for the safe use of ethyl cellulose
as a binder for methionine hydroxy analog to be incorporated into
animal food. The document was published with the incorrect docket
number. This document corrects that error.
FOR FURTHER INFORMATION CONTACT: Lisa Granger, Food and Drug
Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver
Spring, MD 20993-0002, 301-796-9115, lisa.granger@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the Federal Register of Tuesday, November
8, 2016, in FR Doc. 2016-26922, on page 78528, the following correction
is made: On page 78528, in the first column, ``Docket No. FDA-2014-F-
0452'' is corrected to read ``Docket No. FDA-2016-F-3880''.
Dated: November 22, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-28656 Filed 11-28-16; 8:45 am]
BILLING CODE 4164-01-P
